Summary

Definition and Scope:
Lateral flow assay (LFA)-based cardiac markers are rapid diagnostic tests designed to detect biomarkers associated with cardiac conditions, such as troponin, creatine kinase-MB (CK-MB), and myoglobin, which are critical for diagnosing acute myocardial infarction (AMI) and other cardiovascular diseases. These tests utilize immunochromatographic technology, where a sample (typically blood or serum) flows along a test strip, interacting with antibodies to produce a visible result, often within minutes. LFA-based cardiac markers are valued for their portability, ease of use, and quick turnaround time, making them particularly useful in emergency settings, point-of-care testing (POCT), and resource-limited environments where lab-based testing may be unavailable or delayed. However, their sensitivity and specificity may be lower compared to laboratory-based immunoassays, requiring careful interpretation in clinical decision-making. The market for these tests is driven by the increasing prevalence of cardiovascular diseases, the growing demand for rapid diagnostics, and advancements in LFA technology improving accuracy and multiplexing capabilities. Regulatory approvals, cost-effectiveness, and integration with digital health platforms also influence adoption trends.
This report offers a comprehensive analysis of the global LFA-based Cardiac Marker market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.

The global LFA-based Cardiac Marker market size was estimated at USD 4527.9 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.70% during the forecast period.

Report Framework and Key Highlights:
Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the LFA-based Cardiac Marker market.

Global LFA-based Cardiac Marker Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
Thermo Fisher
Bio-Rad Laboratories
Becton, Dickinson
Roche
Hologic
Abbott
Siemens
Danaher
Alere
BioMérieux
LSI
Clinical Diagnostics
Randox laboratories
Wondfo Biotech

Market Segmentation by Type
Troponin
CK-MB
Myoglobin
Others

Market Segmentation by Application
Laboratory Testing
Point-of-care Testing

Geographic Segmentation
North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA

Report Framework and Chapter Summary
Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the LFA-based Cardiac Marker Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapter 4: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 5: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 6: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 7: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapters 8: Regional Market Analysis by Consumption
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 9: Regional Market Analysis by Production
These chapters shares the main producing countries of LFA-based Cardiac Marker, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 12: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.

ページTOPに戻る

Table of Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of LFA-based Cardiac Marker
1.2 Key Market Segments
1.2.1 LFA-based Cardiac Marker Segment by Type
1.2.2 LFA-based Cardiac Marker Segment by Application
1.3 Methodology & Sources of Information
2
3 Global LFA-based Cardiac Marker Market Overview
3.1 Global LFA-based Cardiac Marker Market Overview
3.1.1 Global LFA-based Cardiac Marker Market Size and Forecasts (2020-2035)
3.2 Market Segment Executive Summary
3.3 Global Market Size by Region
4 LFA-based Cardiac Marker Market Competitive Landscape
4.1 Company Assessment Quadrant
4.2 Global LFA-based Cardiac Marker Product Life Cycle
4.3 Global LFA-based Cardiac Marker Sales by Manufacturers (2020-2025)
4.4 Global LFA-based Cardiac Marker Revenue Market Share by Manufacturers (2020-2025)
4.5 LFA-based Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global LFA-based Cardiac Marker Average Price by Manufacturers (2020-2025)
4.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
4.8 LFA-based Cardiac Marker Market Competitive Situation and Trends
4.8.1 LFA-based Cardiac Marker Market Concentration Rate
4.8.2 Global 5 and 10 Largest LFA-based Cardiac Marker Players Market Share by Revenue
4.8.3 Mergers & Acquisitions, Expansion
5 LFA-based Cardiac Marker Industry Chain Analysis
5.1 LFA-based Cardiac Marker Industry Chain Analysis
5.2 Market Overview of Key Raw Materials
5.3 Midstream Market Analysis
5.4 Downstream Customer Analysis
6 The Development and Dynamics of LFA-based Cardiac Marker Market
6.1 Key Development Trends
6.2 Driving Factors
6.3 Market Challenges
6.4 Industry News
6.4.1 New Product Developments
6.4.2 Mergers & Acquisitions
6.4.3 Expansions
6.4.4 Collaboration/Supply Contracts
6.5 PEST Analysis
6.5.1 Political Environment Analysis
6.5.2 Economic Environment Analysis
6.5.3 Social Environment Analysis
6.5.4 Technological Environment Analysis
6.6 Global LFA-based Cardiac Marker Market Porter's Five Forces Analysis
6.6.1 Global Trade Frictions
6.6.2 U.S. Tariff Policy
6.6.3 Global Trade Frictions and Their Impacts on LFA-based Cardiac Marker Market
7 LFA-based Cardiac Marker Market Segmentation by Type
7.1 Evaluation Matrix of Segment Market Development Potential (Type)
7.2 Global LFA-based Cardiac Marker Sales Market Share by Type (2020-2025)
7.3 Global LFA-based Cardiac Marker Market Size by Type (2020-2025)
7.4 Global LFA-based Cardiac Marker Price by Type (2020-2025)
8 LFA-based Cardiac Marker Market Segmentation by Application
8.1 Evaluation Matrix of Segment Market Development Potential (Application)
8.2 Global LFA-based Cardiac Marker Market Sales by Application (2020-2025)
8.3 Global LFA-based Cardiac Marker Market Size (M USD) by Application (2020-2025)
8.4 Global LFA-based Cardiac Marker Sales Growth Rate by Application (2020-2025)
9 LFA-based Cardiac Marker Market Segmentation by Region
9.1 Global LFA-based Cardiac Marker Sales by Region
9.1.1 Global LFA-based Cardiac Marker Sales by Region
9.1.2 Global LFA-based Cardiac Marker Sales Market Share by Region
9.2 Global LFA-based Cardiac Marker Market Size by Region
9.2.1 Global LFA-based Cardiac Marker Market Size by Region
9.2.2 Global LFA-based Cardiac Marker Market Size by Region
9.3 North America
9.3.1 North America LFA-based Cardiac Marker Sales by Country
9.3.2 North America LFA-based Cardiac Marker Market Size by Country
9.3.3 U.S. Market Overview
9.3.4 Canada Market Overview
9.3.5 Mexico Market Overview
9.4 Europe
9.4.1 Europe LFA-based Cardiac Marker Sales by Country
9.4.2 Europe LFA-based Cardiac Marker Market Size by Country
9.4.3 Germany Market Overview
9.4.4 France Market Overview
9.4.5 U.K. Market Overview
9.4.6 Italy Market Overview
9.4.7 Spain Market Overview
9.5 Asia Pacific
9.5.1 Asia Pacific LFA-based Cardiac Marker Sales by Region
9.5.2 Asia Pacific LFA-based Cardiac Marker Market Size by Region
9.5.3 China Market Overview
9.5.4 Japan Market Overview
9.5.5 South Korea Market Overview
9.5.6 India Market Overview
9.5.7 Southeast Asia Market Overview
9.6 South America
9.6.1 South America LFA-based Cardiac Marker Sales by Country
9.6.2 South America LFA-based Cardiac Marker Market Size by Country
9.6.3 Brazil Market Overview
9.6.4 Argentina Market Overview
9.6.5 Columbia Market Overview
9.7 Middle East and Africa
9.7.1 Middle East and Africa LFA-based Cardiac Marker Sales by Region
9.7.2 Middle East and Africa LFA-based Cardiac Marker Market Size by Region
9.7.3 Saudi Arabia Market Overview
9.7.4 UAE Market Overview
9.7.5 Egypt Market Overview
9.7.6 Nigeria Market Overview
9.7.7 South Africa Market Overview
10 LFA-based Cardiac Marker Market Production by Region
10.1 Global Production of LFA-based Cardiac Marker by Region(2020-2025)
10.2 Global LFA-based Cardiac Marker Revenue Market Share by Region (2020-2025)
10.3 Global LFA-based Cardiac Marker Production, Revenue, Price and Gross Margin (2020-2025)
10.4 North America LFA-based Cardiac Marker Production
10.4.1 North America LFA-based Cardiac Marker Production Growth Rate (2020-2025)
10.4.2 North America LFA-based Cardiac Marker Production, Revenue, Price and Gross Margin (2020-2025)
10.5 Europe LFA-based Cardiac Marker Production
10.5.1 Europe LFA-based Cardiac Marker Production Growth Rate (2020-2025)
10.5.2 Europe LFA-based Cardiac Marker Production, Revenue, Price and Gross Margin (2020-2025)
10.6 Japan LFA-based Cardiac Marker Production (2020-2025)
10.6.1 Japan LFA-based Cardiac Marker Production Growth Rate (2020-2025)
10.6.2 Japan LFA-based Cardiac Marker Production, Revenue, Price and Gross Margin (2020-2025)
10.7 China LFA-based Cardiac Marker Production (2020-2025)
10.7.1 China LFA-based Cardiac Marker Production Growth Rate (2020-2025)
10.7.2 China LFA-based Cardiac Marker Production, Revenue, Price and Gross Margin (2020-2025)
11 Key Companies Profile
11.1 Thermo Fisher
11.1.1 Thermo Fisher Basic Information
11.1.2 Thermo Fisher LFA-based Cardiac Marker Product Overview
11.1.3 Thermo Fisher LFA-based Cardiac Marker Product Market Performance
11.1.4 Thermo Fisher Business Overview
11.1.5 Thermo Fisher SWOT Analysis
11.1.6 Thermo Fisher Recent Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Basic Information
11.2.2 Bio-Rad Laboratories LFA-based Cardiac Marker Product Overview
11.2.3 Bio-Rad Laboratories LFA-based Cardiac Marker Product Market Performance
11.2.4 Bio-Rad Laboratories Business Overview
11.2.5 Bio-Rad Laboratories SWOT Analysis
11.2.6 Bio-Rad Laboratories Recent Developments
11.3 Becton, Dickinson
11.3.1 Becton, Dickinson Basic Information
11.3.2 Becton, Dickinson LFA-based Cardiac Marker Product Overview
11.3.3 Becton, Dickinson LFA-based Cardiac Marker Product Market Performance
11.3.4 Becton, Dickinson Business Overview
11.3.5 Becton, Dickinson SWOT Analysis
11.3.6 Becton, Dickinson Recent Developments
11.4 Roche
11.4.1 Roche Basic Information
11.4.2 Roche LFA-based Cardiac Marker Product Overview
11.4.3 Roche LFA-based Cardiac Marker Product Market Performance
11.4.4 Roche Business Overview
11.4.5 Roche Recent Developments
11.5 Hologic
11.5.1 Hologic Basic Information
11.5.2 Hologic LFA-based Cardiac Marker Product Overview
11.5.3 Hologic LFA-based Cardiac Marker Product Market Performance
11.5.4 Hologic Business Overview
11.5.5 Hologic Recent Developments
11.6 Abbott
11.6.1 Abbott Basic Information
11.6.2 Abbott LFA-based Cardiac Marker Product Overview
11.6.3 Abbott LFA-based Cardiac Marker Product Market Performance
11.6.4 Abbott Business Overview
11.6.5 Abbott Recent Developments
11.7 Siemens
11.7.1 Siemens Basic Information
11.7.2 Siemens LFA-based Cardiac Marker Product Overview
11.7.3 Siemens LFA-based Cardiac Marker Product Market Performance
11.7.4 Siemens Business Overview
11.7.5 Siemens Recent Developments
11.8 Danaher
11.8.1 Danaher Basic Information
11.8.2 Danaher LFA-based Cardiac Marker Product Overview
11.8.3 Danaher LFA-based Cardiac Marker Product Market Performance
11.8.4 Danaher Business Overview
11.8.5 Danaher Recent Developments
11.9 Alere
11.9.1 Alere Basic Information
11.9.2 Alere LFA-based Cardiac Marker Product Overview
11.9.3 Alere LFA-based Cardiac Marker Product Market Performance
11.9.4 Alere Business Overview
11.9.5 Alere Recent Developments
11.10 BioMérieux
11.10.1 BioMérieux Basic Information
11.10.2 BioMérieux LFA-based Cardiac Marker Product Overview
11.10.3 BioMérieux LFA-based Cardiac Marker Product Market Performance
11.10.4 BioMérieux Business Overview
11.10.5 BioMérieux Recent Developments
11.11 LSI
11.11.1 LSI Basic Information
11.11.2 LSI LFA-based Cardiac Marker Product Overview
11.11.3 LSI LFA-based Cardiac Marker Product Market Performance
11.11.4 LSI Business Overview
11.11.5 LSI Recent Developments
11.12 Clinical Diagnostics
11.12.1 Clinical Diagnostics Basic Information
11.12.2 Clinical Diagnostics LFA-based Cardiac Marker Product Overview
11.12.3 Clinical Diagnostics LFA-based Cardiac Marker Product Market Performance
11.12.4 Clinical Diagnostics Business Overview
11.12.5 Clinical Diagnostics Recent Developments
11.13 Randox laboratories
11.13.1 Randox laboratories Basic Information
11.13.2 Randox laboratories LFA-based Cardiac Marker Product Overview
11.13.3 Randox laboratories LFA-based Cardiac Marker Product Market Performance
11.13.4 Randox laboratories Business Overview
11.13.5 Randox laboratories Recent Developments
11.14 Wondfo Biotech
11.14.1 Wondfo Biotech Basic Information
11.14.2 Wondfo Biotech LFA-based Cardiac Marker Product Overview
11.14.3 Wondfo Biotech LFA-based Cardiac Marker Product Market Performance
11.14.4 Wondfo Biotech Business Overview
11.14.5 Wondfo Biotech Recent Developments
12 LFA-based Cardiac Marker Market Forecast by Region
12.1 Global LFA-based Cardiac Marker Market Size Forecast
12.2 Global LFA-based Cardiac Marker Market Forecast by Region
12.2.1 North America Market Size Forecast by Country
12.2.2 Europe LFA-based Cardiac Marker Market Size Forecast by Country
12.2.3 Asia Pacific LFA-based Cardiac Marker Market Size Forecast by Region
12.2.4 South America LFA-based Cardiac Marker Market Size Forecast by Country
12.2.5 Middle East and Africa LFA-based Cardiac Marker Market Size Forecast by Country
13 Forecast Market by Type and by Application (2026-2035)
13.1 Global LFA-based Cardiac Marker Market Forecast by Type (2026-2035)
13.1.1 Global Forecasted Sales of LFA-based Cardiac Marker by Type (2026-2035)
13.1.2 Global LFA-based Cardiac Marker Market Size Forecast by Type (2026-2035)
13.1.3 Global Forecasted Price of LFA-based Cardiac Marker by Type (2026-2035)
13.2 Global LFA-based Cardiac Marker Market Forecast by Application (2026-2035)
13.2.1 Global LFA-based Cardiac Marker Sales (K Units) Forecast by Application
13.2.2 Global LFA-based Cardiac Marker Market Size (M USD) Forecast by Application (2026-2035)
14 Conclusion and Key Findings

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global LFA-based Cardiac Marker Market Size by Type (M USD)
Table 4. Global LFA-based Cardiac Marker Market Size by Application
Table 5. LFA-based Cardiac Marker Market Size Comparison by Region (M USD)
Table 6. LFA-based Cardiac Marker Market Size by Country (M USD)
Table 7. Global LFA-based Cardiac Marker Sales (K Units) by Manufacturers (2020-2025)
Table 8. Global LFA-based Cardiac Marker Sales Market Share by Manufacturers (2020-2025)
Table 9. Global LFA-based Cardiac Marker Revenue (M USD) by Manufacturers (2020-2025)
Table 10. Global LFA-based Cardiac Marker Revenue Share by Manufacturers (2020-2025)
Table 11. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac Marker as of 2025)
Table 12. Global Market LFA-based Cardiac Marker Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 13. Manufacturers’ Manufacturing Sites, Areas Served
Table 14. Manufacturers’ Product Type
Table 15. Global LFA-based Cardiac Marker Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Market Overview of Key Raw Materials
Table 18. Midstream Market Lists
Table 19. Downstream Customer Analysis
Table 20. Key Development Trends
Table 21. Driving Factors
Table 22. LFA-based Cardiac Marker Market Challenges
Table 23. World Bank's Forecast Real GDP Growth Rate for 2024-2028
Table 24. Goldman Sachs' Forecast Real GDP Growth Rate for 2025-2026
Table 25. IMF's Forecast Real GDP Growth Rate For 2024-2026
Table 26. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 27. Global LFA-based Cardiac Marker Sales by Type (K Units)
Table 28. Global LFA-based Cardiac Marker Market Size by Type (M USD)
Table 29. Global LFA-based Cardiac Marker Sales (K Units) by Type (2020-2025)
Table 30. Global LFA-based Cardiac Marker Sales Market Share by Type (2020-2025)
Table 31. Global LFA-based Cardiac Marker Market Size (M USD) by Type (2020-2025)
Table 32. Global LFA-based Cardiac Marker Market Share by Type (2020-2025)
Table 33. Global LFA-based Cardiac Marker Price (USD/Unit) by Type (2020-2025)
Table 34. Global LFA-based Cardiac Marker Sales (K Units) by Application
Table 35. Global LFA-based Cardiac Marker Market Size by Application
Table 36. Global LFA-based Cardiac Marker Sales by Application (2020-2025) & (K Units)
Table 37. Global LFA-based Cardiac Marker Sales Market Share by Application (2020-2025)
Table 38. Global LFA-based Cardiac Marker Market Size by Application (2020-2025) & (M USD)
Table 39. Global LFA-based Cardiac Marker Market Share by Application (2020-2025)
Table 40. Global LFA-based Cardiac Marker Sales Growth Rate by Application (2020-2025)
Table 41. Global LFA-based Cardiac Marker Sales by Region (2020-2025) & (K Units)
Table 42. Global LFA-based Cardiac Marker Sales Market Share by Region (2020-2025)
Table 43. Global LFA-based Cardiac Marker Market Size by Region (2020-2025) & (M USD)
Table 44. Global LFA-based Cardiac Marker Market Size by Region (2020-2025)
Table 45. North America LFA-based Cardiac Marker Sales by Country (2020-2025) & (K Units)
Table 46. North America LFA-based Cardiac Marker Market Size by Country (2020-2025) & (M USD)
Table 47. Europe LFA-based Cardiac Marker Sales by Country (2020-2025) & (K Units)
Table 48. Europe LFA-based Cardiac Marker Market Size by Country (2020-2025) & (M USD)
Table 49. Asia Pacific LFA-based Cardiac Marker Sales by Region (2020-2025) & (K Units)
Table 50. Asia Pacific LFA-based Cardiac Marker Market Size by Region (2020-2025) & (M USD)
Table 51. South America LFA-based Cardiac Marker Sales by Country (2020-2025) & (K Units)
Table 52. South America LFA-based Cardiac Marker Market Size by Country (2020-2025) & (M USD)
Table 53. Middle East and Africa LFA-based Cardiac Marker Sales by Region (2020-2025) & (K Units)
Table 54. Middle East and Africa LFA-based Cardiac Marker Market Size by Region (2020-2025) & (M USD)
Table 55. Global LFA-based Cardiac Marker Production (K Units) by Region(2020-2025)
Table 56. Global LFA-based Cardiac Marker Revenue (US$ Million) by Region (2020-2025)
Table 57. Global LFA-based Cardiac Marker Revenue Market Share by Region (2020-2025)
Table 58. Global LFA-based Cardiac Marker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. North America LFA-based Cardiac Marker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Europe LFA-based Cardiac Marker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Japan LFA-based Cardiac Marker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. China LFA-based Cardiac Marker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Thermo Fisher Basic Information
Table 64. Thermo Fisher LFA-based Cardiac Marker Product Overview
Table 65. Thermo Fisher LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 66. Thermo Fisher Business Overview
Table 67. Thermo Fisher SWOT Analysis
Table 68. Thermo Fisher Recent Developments
Table 69. Bio-Rad Laboratories Basic Information
Table 70. Bio-Rad Laboratories LFA-based Cardiac Marker Product Overview
Table 71. Bio-Rad Laboratories LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories SWOT Analysis
Table 74. Bio-Rad Laboratories Recent Developments
Table 75. Becton, Dickinson Basic Information
Table 76. Becton, Dickinson LFA-based Cardiac Marker Product Overview
Table 77. Becton, Dickinson LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Becton, Dickinson Business Overview
Table 79. Becton, Dickinson SWOT Analysis
Table 80. Becton, Dickinson Recent Developments
Table 81. Roche Basic Information
Table 82. Roche LFA-based Cardiac Marker Product Overview
Table 83. Roche LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Roche Business Overview
Table 85. Roche Recent Developments
Table 86. Hologic Basic Information
Table 87. Hologic LFA-based Cardiac Marker Product Overview
Table 88. Hologic LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. Hologic Business Overview
Table 90. Hologic Recent Developments
Table 91. Abbott Basic Information
Table 92. Abbott LFA-based Cardiac Marker Product Overview
Table 93. Abbott LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. Abbott Business Overview
Table 95. Abbott Recent Developments
Table 96. Siemens Basic Information
Table 97. Siemens LFA-based Cardiac Marker Product Overview
Table 98. Siemens LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Siemens Business Overview
Table 100. Siemens Recent Developments
Table 101. Danaher Basic Information
Table 102. Danaher LFA-based Cardiac Marker Product Overview
Table 103. Danaher LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Danaher Business Overview
Table 105. Danaher Recent Developments
Table 106. Alere Basic Information
Table 107. Alere LFA-based Cardiac Marker Product Overview
Table 108. Alere LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Alere Business Overview
Table 110. Alere Recent Developments
Table 111. BioMérieux Basic Information
Table 112. BioMérieux LFA-based Cardiac Marker Product Overview
Table 113. BioMérieux LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. BioMérieux Business Overview
Table 115. BioMérieux Recent Developments
Table 116. LSI Basic Information
Table 117. LSI LFA-based Cardiac Marker Product Overview
Table 118. LSI LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 119. LSI Business Overview
Table 120. LSI Recent Developments
Table 121. Clinical Diagnostics Basic Information
Table 122. Clinical Diagnostics LFA-based Cardiac Marker Product Overview
Table 123. Clinical Diagnostics LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 124. Clinical Diagnostics Business Overview
Table 125. Clinical Diagnostics Recent Developments
Table 126. Randox laboratories Basic Information
Table 127. Randox laboratories LFA-based Cardiac Marker Product Overview
Table 128. Randox laboratories LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 129. Randox laboratories Business Overview
Table 130. Randox laboratories Recent Developments
Table 131. Wondfo Biotech Basic Information
Table 132. Wondfo Biotech LFA-based Cardiac Marker Product Overview
Table 133. Wondfo Biotech LFA-based Cardiac Marker Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 134. Wondfo Biotech Business Overview
Table 135. Wondfo Biotech Recent Developments
Table 136. Global LFA-based Cardiac Marker Sales Forecast by Region (2026-2035) & (K Units)
Table 137. Global LFA-based Cardiac Marker Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. North America LFA-based Cardiac Marker Sales Forecast by Country (2026-2035) & (K Units)
Table 139. North America LFA-based Cardiac Marker Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Europe LFA-based Cardiac Marker Sales Forecast by Country (2026-2035) & (K Units)
Table 141. Europe LFA-based Cardiac Marker Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Asia Pacific LFA-based Cardiac Marker Sales Forecast by Region (2026-2035) & (K Units)
Table 143. Asia Pacific LFA-based Cardiac Marker Market Size Forecast by Region (2026-2035) & (M USD)
Table 144. South America LFA-based Cardiac Marker Sales Forecast by Country (2026-2035) & (K Units)
Table 145. South America LFA-based Cardiac Marker Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Middle East and Africa LFA-based Cardiac Marker Sales Forecast by Country (2026-2035) & (K Units)
Table 147. Middle East and Africa LFA-based Cardiac Marker Market Size Forecast by Country (2026-2035) & (M USD)
Table 148. Global LFA-based Cardiac Marker Sales Forecast by Type (2026-2035) & (K Units)
Table 149. Global LFA-based Cardiac Marker Market Size Forecast by Type (2026-2035) & (M USD)
Table 150. Global LFA-based Cardiac Marker Price Forecast by Type (2026-2035) & (USD/Unit)
Table 151. Global LFA-based Cardiac Marker Sales (K Units) Forecast by Application (2026-2035)
Table 152. Global LFA-based Cardiac Marker Market Size Forecast by Application (2026-2035) & (M USD)
List of Figures
Figure 1. Product Picture of LFA-based Cardiac Marker
Figure 2. Global LFA-based Cardiac Marker Market Size (M USD) (2020-2035)
Figure 3. Global LFA-based Cardiac Marker Sales (K Units) & (2020-2035)
Figure 4. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 5. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 6. Evaluation Matrix of Regional Market Development Potential
Figure 7. Company Assessment Quadrant
Figure 8. Global LFA-based Cardiac Marker Product Life Cycle
Figure 9. LFA-based Cardiac Marker Sales Share by Manufacturers in 2025
Figure 10. Global LFA-based Cardiac Marker Revenue Share by Manufacturers in 2025
Figure 11. LFA-based Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 12. Global Market LFA-based Cardiac Marker Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 13. The Global 5 and 10 Largest Players: Market Share by LFA-based Cardiac Marker Revenue in 2025
Figure 14. Industry Chain Map of LFA-based Cardiac Marker
Figure 15. LFA-based Cardiac Marker Market Share of Key Raw Materials (2025)
Figure 16. Key Driving Factors - Impact Assessment
Figure 17. Market Challenges - Severity vs. Frequency Matrix
Figure 18. Key Industry News Timeline
Figure 19. PEST Analysis
Figure 20. Global LFA-based Cardiac Marker Market PEST Analysis
Figure 21. Global LFA-based Cardiac Marker Market Porter's Five Forces Analysis
Figure 22. Global Merchandise Trade as a Percentage Of GDP
Figure 23. US - lmports of Goods by Country
Figure 24. China Exports by Country
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global LFA-based Cardiac Marker Market Share by Type
Figure 27. Sales Market Share of LFA-based Cardiac Marker by Type (2020-2025)
Figure 28. Sales Market Share of LFA-based Cardiac Marker by Type in 2025
Figure 29. Market Share of LFA-based Cardiac Marker by Type (2020-2025)
Figure 30. Market Share of LFA-based Cardiac Marker by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global LFA-based Cardiac Marker Market Share by Application
Figure 33. Global LFA-based Cardiac Marker Sales Market Share by Application (2020-2025)
Figure 34. Global LFA-based Cardiac Marker Sales Market Share by Application in 2025
Figure 35. Global LFA-based Cardiac Marker Market Share by Application (2020-2025)
Figure 36. Global LFA-based Cardiac Marker Market Share by Application in 2025
Figure 37. Global LFA-based Cardiac Marker Sales Growth Rate by Application (2020-2025)
Figure 38. Global LFA-based Cardiac Marker Sales Market Share by Region (2020-2025)
Figure 39. Global LFA-based Cardiac Marker Market Size by Region (2020-2025)
Figure 40. North America LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America LFA-based Cardiac Marker Sales Market Share by Country in 2024
Figure 42. North America LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. North America LFA-based Cardiac Marker Market Size by Country in 2024
Figure 44. U.S. LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 45. U.S. LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Canada LFA-based Cardiac Marker Sales (K Units) and Growth Rate (2020-2025)
Figure 47. Canada LFA-based Cardiac Marker Market Size (M USD) and Growth Rate (2020-2025)
Figure 48. Mexico LFA-based Cardiac Marker Sales (K Units) and Growth Rate (2020-2025)
Figure 49. Mexico LFA-based Cardiac Marker Market Size (M USD) and Growth Rate (2020-2025)
Figure 50. Europe LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 51. Europe LFA-based Cardiac Marker Sales Market Share by Country in 2024
Figure 52. Europe LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Europe LFA-based Cardiac Marker Market Size by Country in 2024
Figure 54. Germany LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 55. Germany LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. France LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 57. France LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. U.K. LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 59. U.K. LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Italy LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 61. Italy LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 62. Spain LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 63. Spain LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 64. Asia Pacific LFA-based Cardiac Marker Sales and Growth Rate (K Units)
Figure 65. Asia Pacific LFA-based Cardiac Marker Sales Market Share by Region in 2024
Figure 66. Asia Pacific LFA-based Cardiac Marker Market Size by Region in 2024
Figure 67. China LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. China LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Japan LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Japan LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. South Korea LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 72. South Korea LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 73. India LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 74. India LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 75. Southeast Asia LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 76. Southeast Asia LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 77. South America LFA-based Cardiac Marker Sales and Growth Rate (K Units)
Figure 78. South America LFA-based Cardiac Marker Sales Market Share by Country in 2024
Figure 79. South America LFA-based Cardiac Marker Market Size and Growth Rate (M USD)
Figure 80. South America LFA-based Cardiac Marker Market Size by Country in 2024
Figure 81. Brazil LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 82. Brazil LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 83. Argentina LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 84. Argentina LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 85. Columbia LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 86. Columbia LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 87. Middle East and Africa LFA-based Cardiac Marker Sales and Growth Rate (K Units)
Figure 88. Middle East and Africa LFA-based Cardiac Marker Sales Market Share by Region in 2024
Figure 89. Middle East and Africa LFA-based Cardiac Marker Market Size and Growth Rate (M USD)
Figure 90. Middle East and Africa LFA-based Cardiac Marker Market Size by Region in 2024
Figure 91. Saudi Arabia LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 92. Saudi Arabia LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 93. UAE LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 94. UAE LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 95. Egypt LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 96. Egypt LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 97. Nigeria LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 98. Nigeria LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 99. South Africa LFA-based Cardiac Marker Sales and Growth Rate (2020-2025) & (K Units)
Figure 100. South Africa LFA-based Cardiac Marker Market Size and Growth Rate (2020-2025) & (M USD)
Figure 101. Global LFA-based Cardiac Marker Production Market Share by Region (2020-2025)
Figure 102. North America LFA-based Cardiac Marker Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe LFA-based Cardiac Marker Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan LFA-based Cardiac Marker Production (K Units) Growth Rate (2020-2025)
Figure 105. China LFA-based Cardiac Marker Production (K Units) Growth Rate (2020-2025)
Figure 106. Global LFA-based Cardiac Marker Sales Forecast by Volume (2020-2035) & (K Units)
Figure 107. Global LFA-based Cardiac Marker Market Size Forecast by Value (2020-2035) & (M USD)
Figure 108. Global LFA-based Cardiac Marker Sales Market Share Forecast by Type (2026-2035)
Figure 109. Global LFA-based Cardiac Marker Market Share Forecast by Type (2026-2035)
Figure 110. Global LFA-based Cardiac Marker Sales Forecast by Application (2026-2035)
Figure 111. Global LFA-based Cardiac Marker Market Share Forecast by Application (2026-2035)